Mutual Pharmaceutical Recalls Ergoloid Mesylates Tablets Due to Impurities
Mutual Pharmaceutical is recalling Ergoloid Mesylates 1 mg tablets because they failed impurity and degradation specifications during stability testing.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving potential adverse health consequences from impurities, even if specific hospitalization reports are not detailed in the provided text snippet.
Plain-English summary
Mutual Pharmaceutical Company, Inc. is recalling Ergoloid Mesylates 1 mg tablets, 100-count bottles, NDC 53489-281-01. The recall involves 23,246 bottles distributed nationwide. The affected lots are 6557301, 6557401, and 6557501 (all expiring 3/15), 6656301 (expiring 10/16), and 6687701 (expiring 4/17).
The recall was initiated because the product failed impurities and degradation specifications during long-term stability testing. The FDA has classified this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or healthcare provider for guidance on replacement or disposal. The product is prescription-only and was manufactured by Mutual Pharmaceutical Company, Inc. for Sun Pharmaceutical Industries, Inc.
The recalled product
- Product
- Ergoloid Mesylates ,1 mg tablets, 100 count bottle, Rx only, Manufactured by MUTUAL PHARMACEUTICAL CO., INC., PHILADELPHIA, PA 19124 USA for Sun Pharmaceutical Industries, Inc. 270 Prospect Plains Road, Cranbury, NJ 08512. NDC 53489-281-01
- Manufacturer
- Mutual Pharmaceutical Company, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 23,246
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #: 6557301
- Exp 3/15
- 6557401
- 6557501
- 6656301
- Exp 10/16
- 6687701
- Exp 4/17.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Mutual Pharmaceutical Company, Inc.
See all →- ModerateMutual Pharmaceutical Recalls Sulfamethoxazole and Trimethoprim Tablets Due to Foreign Substance
FDA (Drugs) · 2016-01-27
- ModerateMutual Pharmaceutical Recalls Imipramine HCl Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
- LowMutual Pharmaceutical Recalls Felodipine Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
- LowMutual Pharmaceutical Recalls Imipramine HCl Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
- ModerateMutual Pharmaceutical Recalls Felodipine Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08